JP2023525565A5 - - Google Patents
Info
- Publication number
- JP2023525565A5 JP2023525565A5 JP2022568912A JP2022568912A JP2023525565A5 JP 2023525565 A5 JP2023525565 A5 JP 2023525565A5 JP 2022568912 A JP2022568912 A JP 2022568912A JP 2022568912 A JP2022568912 A JP 2022568912A JP 2023525565 A5 JP2023525565 A5 JP 2023525565A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- approximately
- composition according
- aqueous solution
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063022853P | 2020-05-11 | 2020-05-11 | |
| US63/022,853 | 2020-05-11 | ||
| PCT/US2021/031611 WO2021231316A1 (en) | 2020-05-11 | 2021-05-10 | Il-2 fusion polypeptide compositions and methods of making and using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023525565A JP2023525565A (ja) | 2023-06-16 |
| JP2023525565A5 true JP2023525565A5 (enExample) | 2024-05-22 |
Family
ID=78524918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568912A Pending JP2023525565A (ja) | 2020-05-11 | 2021-05-10 | Ｉｌ－２融合ポリペプチド組成物ならびにその作製及び使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210371486A1 (enExample) |
| EP (1) | EP4149515A4 (enExample) |
| JP (1) | JP2023525565A (enExample) |
| KR (1) | KR20230009446A (enExample) |
| CN (1) | CN115916242A (enExample) |
| AU (1) | AU2021270745A1 (enExample) |
| BR (1) | BR112022022764A2 (enExample) |
| CA (1) | CA3172871A1 (enExample) |
| IL (1) | IL298065A (enExample) |
| MX (1) | MX2022014164A (enExample) |
| TW (1) | TW202207970A (enExample) |
| WO (1) | WO2021231316A1 (enExample) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1292686C (en) * | 1986-10-27 | 1991-12-03 | Ze'ev Shaked | Pharmaceutical compositions of recombinant interleukin-2 and formulation process |
| SK11142002A3 (sk) * | 1999-12-30 | 2004-09-08 | Chiron Corporation | Liečivo na podávanie interleukínu-2 a stabilizovaný lyofilizovaný alebo sprejovo sušený farmaceutický prostriedok s obsahom interleukínu-2 |
| CN1816356A (zh) * | 2003-05-14 | 2006-08-09 | 免疫原公司 | 药物缀合物组合物 |
| JP2006137678A (ja) * | 2004-11-10 | 2006-06-01 | Shionogi & Co Ltd | インターロイキン−２組成物 |
| US9156897B2 (en) * | 2012-06-08 | 2015-10-13 | Alkermes, Inc. | Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide |
| US10016415B2 (en) * | 2014-08-18 | 2018-07-10 | Alkermes Pharma Ireland Limited | Aripiprazole prodrug compositions |
| AU2015364396B2 (en) * | 2014-12-19 | 2018-08-09 | Alkermes, Inc. | Single chain Fc fusion proteins |
| WO2019019998A1 (zh) * | 2017-07-25 | 2019-01-31 | 江苏恒瑞医药股份有限公司 | 一种il-15蛋白复合物药物组合物及其用途 |
| US20210038684A1 (en) * | 2019-06-11 | 2021-02-11 | Alkermes Pharma Ireland Limited | Compositions and Methods for Cancer Immunotherapy |
| BR112022007158A2 (pt) * | 2019-10-18 | 2022-07-05 | Alkermes Pharma Ireland Ltd | Agentes imunomodulatórios de il-2 em combinação com inibidores do ponto de verificação imunológico |
| EP4093755A4 (en) * | 2020-01-24 | 2024-07-31 | Alkermes Pharma Ireland Limited | PURIFICATION PROCESSES |
-
2021
- 2021-05-10 KR KR1020227043013A patent/KR20230009446A/ko not_active Withdrawn
- 2021-05-10 CA CA3172871A patent/CA3172871A1/en active Pending
- 2021-05-10 JP JP2022568912A patent/JP2023525565A/ja active Pending
- 2021-05-10 CN CN202180042991.8A patent/CN115916242A/zh active Pending
- 2021-05-10 EP EP21804863.5A patent/EP4149515A4/en not_active Withdrawn
- 2021-05-10 IL IL298065A patent/IL298065A/en unknown
- 2021-05-10 WO PCT/US2021/031611 patent/WO2021231316A1/en not_active Ceased
- 2021-05-10 MX MX2022014164A patent/MX2022014164A/es unknown
- 2021-05-10 BR BR112022022764A patent/BR112022022764A2/pt not_active Application Discontinuation
- 2021-05-10 US US17/315,973 patent/US20210371486A1/en not_active Abandoned
- 2021-05-10 AU AU2021270745A patent/AU2021270745A1/en not_active Abandoned
- 2021-05-11 TW TW110116903A patent/TW202207970A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010511665A5 (enExample) | ||
| US6987108B2 (en) | Pharmaceutical formulations of antineoplastic agents and processes of making and using the same | |
| JP7229999B2 (ja) | ダプトマイシン製剤 | |
| FI86144C (fi) | Foerfarande foer framstaellning av farmaceutiska preparatformer foer topisk anvaendning foer stabilisering av -interferon. | |
| CN101272764B (zh) | hFSH水制剂 | |
| JP2000508665A (ja) | 成長ホルモン、アミノ酸及び非イオン洗浄剤を含有する医薬配合物 | |
| JP2003505482A (ja) | ロタウイルスワクチン調合物 | |
| JP4653262B2 (ja) | ロタウイルスワクチン製剤類 | |
| JP2022151814A5 (enExample) | ||
| JPS59181224A (ja) | 安定なインタ−フエロン製剤の製法 | |
| CN101056623B (zh) | 稳定的头孢菌素衍生物冻干制剂 | |
| US6497869B2 (en) | Stabilized granulocyte colony stimulating factor | |
| AU2020311050B2 (en) | Stable formulations of recombinant proteins | |
| JP2023525565A5 (enExample) | ||
| KR101838759B1 (ko) | 점안제 | |
| JPS5940143B2 (ja) | ペプチド組成物の製法 | |
| JP2024546804A5 (enExample) | ||
| JP2023516957A (ja) | ダプトマイシン製剤 | |
| JP2024535845A5 (enExample) | ||
| RU2566725C1 (ru) | Комбинированный препарат для парентерального введения, содержащий гидрохлорид или сукцинат метилэтилпиридинола и рибофлавин | |
| JP2023526024A5 (enExample) | ||
| JPS62252730A (ja) | 抗腫瘍剤 | |
| JPH0378848B2 (enExample) | ||
| JP2025518274A5 (enExample) | ||
| JP2023501155A5 (enExample) |